Top 5 Drug Type | Count |
---|---|
Small molecule drug | 22 |
Unknown | 3 |
Monoclonal antibody | 1 |
Probiotics | 1 |
Target |
Mechanism α4β1 antagonists [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date28 Mar 2022 |
Target |
Mechanism CaSR modulators |
Active Org. ![]() |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date23 Jun 2021 |
Target |
Mechanism ISBT inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date19 Jan 2018 |
Start Date01 Dec 2023 |
Sponsor / Collaborator |
Start Date21 Jun 2023 |
Sponsor / Collaborator |
Start Date28 Feb 2022 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Bisacodyl | Constipation More | Approved |
Polyethylene glycol 4000 | Constipation More | Approved |
Macrogol 4000/Sodium Bicarbonate/Sodium Chloride/Potassium Chloride | Constipation More | Approved |
Cilnidipine ( Cav1.2 x Cav2.2 ) | Hypertension More | Approved |
Budesonide ( GR ) | Colitis, Ulcerative More | Approved |